Next-Generation GLP-1 Drugs Beyond Semaglutide Success
The pharmaceutical landscape has witnessed a seismic shift over the last decade, transitioning from the incremental management of chronic conditions to what many clinicians...
GLP-1 Contract Manufacturing Driving CDMO Growth Globally
The pharmaceutical landscape is currently witnessing a seismic shift driven by a single class of drugs that has captured the global imagination: glucagon-like peptide-1...
GLP-1 Combination Therapies for Metabolic Disease Treatment
For decades, the medical community viewed metabolic health through a relatively narrow lens, often compartmentalizing conditions like type 2 diabetes and obesity as distinct...
Artificial Intelligence Boosting GLP-1 Drug Discovery
The pharmaceutical landscape is currently witnessing a seismic shift driven by the unprecedented demand for glucagon-like peptide-1 (GLP-1) receptor agonists. These therapies, which have...
Closed Loop Powder Containment Enabling Modern API Conveying
Closed-loop powder containment is rapidly becoming the most critical infrastructure requirement for the handling and conveying of Active Pharmaceutical Ingredients (APIs), particularly as the...
Wash in Place Systems Powering Hygienic Pharma Conveyors
The evolution of hygienic design in the pharmaceutical industry has reached a pivotal moment with the widespread adoption of Wash-in-Place (WIP) systems for conveyor...
Modular Conveyor Architectures Boosting Pharma Production
Modular conveyor architectures are fundamentally redefining the layout and operational capabilities of modern pharmaceutical manufacturing facilities. In an industry that is rapidly moving away...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...